Clinical Trial Update: An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update of an individualized anti-cancer vaccine in adults with advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• An Individualized Anti-Cancer Vaccine

Snippet

Sponsor: Mirror Biologics, Inc. | Conditions: Advanced Adult Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED